KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $277,514 | -39.5% | 19,965 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $458,995 | -22.4% | 19,965 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $591,563 | +18.7% | 19,965 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $498,326 | +2.9% | 19,965 | -10.2% | 0.00% | 0.0% |
| Q3 2022 | $484,121 | +27.9% | 22,238 | +15.7% | 0.00% | +33.3% |
| Q2 2022 | $378,599 | -53.5% | 19,228 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $813,729 | +4.7% | 19,228 | +57.0% | 0.01% | -28.6% |
| Q4 2021 | $777,562 | +8.1% | 12,247 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $719,389 | +32.6% | 12,247 | +9.5% | 0.01% | +40.0% |
| Q2 2021 | $542,424 | +206.8% | 11,184 | +145.9% | 0.01% | +150.0% |
| Q1 2021 | $176,774 | -37.3% | 4,549 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $282,038 | – | 4,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |